Signed MOU for business cooperation with Heifle Life Science

Daeryun Law Firm (Limited) signed an MOU with pharmaceutical manufacturer Hiple Life Science Co., Ltd. on November 14, 2024.
 

At the MOU signing ceremony held at the headquarters of Hyple Co., Ltd. located in Bundang-gu, Seongnam-si, Daeryun's Corporate Legal Group Head Won Won-il and Hyple Life Science CEO Cho Jae-min attended.

Hypl Life Science is a subsidiary of Hypl Co., Ltd. and is a pharmaceutical company with 55 years of business established in 1970. Hiple Life Science, which has grown as ‘Korea’s only company specializing in the treatment of kidney diseases,’ is currently expanding its scope to produce various specialized treatment drugs and distributing them to domestic and foreign pharmaceutical companies.

Through this MOU, Daeryun is providing information to Hiple Life Science ▲ Transaction contract related laws We plan to provide specialized legal services to the pharmaceutical industry, including consultation, ▲ review of domestic and international drug regulations, ▲ product dispute resolution and litigation support.

In particular, as Hipple Life Science is working on developing new drugs, Daeryun's The policy is to provide legal assistance from a comprehensive perspective by collaborating with professional teams in each group, including the pharmaceutical bio and healthcare team and the intellectual property rights team. He said, “I am satisfied with the help I am getting, and expressed my desire for an MOU to obtain additional support for my subsidiaries.” He added, “In the pharmaceutical industry, intellectual property rights are a core asset of a company and the basis of its competitiveness. We will be able to reduce legal risks in the domestic and overseas markets and promote stable growth through professional legal support from Daeryun, which has extensive relevant experience.” style="background-color:rgb(255,255,255);color:rgb(30,30,30);">Won Won-il, head of the corporate legal group at Daeryun Law Firm (Limited), said, “Through this MOU, we will focus on providing necessary legal advice to Hiple Life Science and increasing competitiveness,” and added, “Daeryun is operating the corporate legal group and the intellectual property rights group, while lower-level teams are moving systematically. Patents, trademarks, etc. “We will systematically protect corporate rights and work hard to ensure that Hipple Life Science’s rights are not infringed in the pharmaceutical industry, where intellectual property is the competitive edge, and we will help with stable business expansion.”